Search Results

There are 15169 results for: content related to: Striking dichotomy in outcome of MYCN -amplified neuroblastoma in the contemporary era

  1. You have free access to this content
    Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group


    Volume 119, Issue 20, 15 October 2013, Pages: 3718–3726, Larry L. Wang, Rie Suganuma, Naohiko Ikegaki, Xao Tang, Arlene Naranjo, Patrick McGrady, Wendy B. London, Michael D. Hogarty, Julie M. Gastier-Foster, A. Thomas Look, Julie R. Park, John M. Maris, Susan L. Cohn, Robert C. Seeger and Hiroyuki Shimada

    Version of Record online : 30 JUL 2013, DOI: 10.1002/cncr.28251

  2. You have free access to this content
    Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations


    Volume 122, Issue 1, January 1, 2016, Pages: 20–33, Kristopher R. Bosse and John M. Maris

    Version of Record online : 5 NOV 2015, DOI: 10.1002/cncr.29706

  3. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project


    Volume 122, Issue 6, March 15, 2016, Pages: 935–945, Daria Thompson, Kieuhoa T. Vo, Wendy B. London, Matthias Fischer, Peter F. Ambros, Akira Nakagawara, Garrett M. Brodeur, Katherine K. Matthay and Steven G. DuBois

    Version of Record online : 28 DEC 2015, DOI: 10.1002/cncr.29848

  4. You have free access to this content
    Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma

    International Journal of Cancer

    Volume 132, Issue 3, 1 February 2013, Pages: E106–E115, Alexander Schramm, Johannes Köster, Tobias Marschall, Marcel Martin, Melanie Schwermer, Kathrin Fielitz, Gabriele Büchel, Matthias Barann, Daniela Esser, Philip Rosenstiel, Sven Rahmann, Angelika Eggert and Johannes H. Schulte

    Version of Record online : 26 SEP 2012, DOI: 10.1002/ijc.27787

  5. MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines

    Genes, Chromosomes and Cancer

    Volume 54, Issue 10, October 2015, Pages: 616–628, Alexandra Kuzyk, Samuel Booth, Christiaan Righolt, Shubha Mathur, John Gartner and Sabine Mai

    Version of Record online : 14 JUL 2015, DOI: 10.1002/gcc.22273

  6. You have full text access to this Open Access content
    Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation

    Molecular Oncology

    Volume 9, Issue 7, August 2015, Pages: 1301–1311, Hailong Zhang, Tao Liu, Sha Yi, Lubing Gu, Muxiang Zhou

    Version of Record online : 24 MAR 2015, DOI: 10.1016/j.molonc.2015.03.005

  7. You have free access to this content
    Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase

    Journal of Neurochemistry

    Volume 113, Issue 4, May 2010, Pages: 819–825, Miguel Veas-Perez De Tudela, María Delgado-Esteban, Julia Cuende, Juan P. Bolaños and Angeles Almeida

    Version of Record online : 17 FEB 2010, DOI: 10.1111/j.1471-4159.2010.06648.x

  8. You have full text access to this OnlineOpen article
    MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines

    FEBS Open Bio

    Volume 4, Issue 1, January 01, 2014, Pages: 966–975, Ingo Lange and Dana-Lynn T. Koomoa

    Version of Record online : 30 OCT 2014, DOI: 10.1016/j.fob.2014.10.012

  9. You have full text access to this OnlineOpen article
    Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas

    Cancer Science

    Volume 106, Issue 7, July 2015, Pages: 840–847, Yoshiki Kaneko, Yusuke Suenaga, S. M. Rafiqul Islam, Daisuke Matsumoto, Yohko Nakamura, Miki Ohira, Sana Yokoi and Akira Nakagawara

    Version of Record online : 19 MAY 2015, DOI: 10.1111/cas.12677

  10. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification

    The Journal of Pathology

    Volume 198, Issue 4, December 2002, Pages: 495–501, Alexander Valent, Gwenaëlle Le Roux, Michel Barrois, Marie-José Terrier-Lacombe, Dominique Valteau-Couanet, Bernadette Léon, Barbara Spengler, Gilbert Lenoir, Jean Bénard and Alain Bernheim

    Version of Record online : 14 OCT 2002, DOI: 10.1002/path.1244

  11. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  12. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples

    The Journal of Pathology

    Volume 196, Issue 4, April 2002, Pages: 450–458, Luisa Toffolatti, Emanuela Frascella, Vito Ninfo, Claudio Gambini, Marco Forni, Modesto Carli and Angelo Rosolen

    Version of Record online : 11 FEB 2002, DOI: 10.1002/path.1068

  13. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis

    Molecular Carcinogenesis

    Volume 50, Issue 6, June 2011, Pages: 403–411, Derek M. Murphy, Patrick G. Buckley, Kenneth Bryan, Karen M. Watters, Jan Koster, Peter van Sluis, Jan Molenaar, Rogier Versteeg and Raymond L. Stallings

    Version of Record online : 28 DEC 2010, DOI: 10.1002/mc.20722

  14. You have full text access to this Open Access content
    WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma

    Molecular Oncology

    Volume 10, Issue 2, February 2016, Pages: 240–252, Caroline Masserot, Qingyuan Liu, Eric Nguyen, Charles-Henry Gattolliat, Dominique Valteau-Couanet, Jean Bénard, Catherine Huber, Evelyne Ségal-Bendirdjian

    Version of Record online : 21 OCT 2015, DOI: 10.1016/j.molonc.2015.09.010

  15. You have free access to this content
    Targeted expression of MYCN causes neuroblastoma in transgenic mice

    The EMBO Journal

    Volume 16, Issue 11, June 1, 1997, Pages: 2985–2995, William A. Weiss, Ken Aldape, Gayatry Mohapatra, Burt G. Feuerstein and J.Michael Bishop

    Version of Record online : 1 JUN 1997, DOI: 10.1093/emboj/16.11.2985

  16. You have free access to this content
    Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis

    Genes, Chromosomes and Cancer

    Volume 56, Issue 1, January 2017, Pages: 28–41, Paula Marrano, Meredith S. Irwin and Paul S. Thorner

    Version of Record online : 18 AUG 2016, DOI: 10.1002/gcc.22398

  17. You have free access to this content
    MYCN regulates oncogenic MicroRNAs in neuroblastoma

    International Journal of Cancer

    Volume 122, Issue 3, 1 February 2008, Pages: 699–704, Johannes H. Schulte, Sebastian Horn, Tobias Otto, Birgit Samans, Lukas C. Heukamp, Ursula-Christa Eilers, Michael Krause, Kathy Astrahantseff, Ludger Klein-Hitpass, Reinhard Buettner, Alexander Schramm, Holger Christiansen, Martin Eilers, Angelika Eggert and Bernd Berwanger

    Version of Record online : 17 OCT 2007, DOI: 10.1002/ijc.23153

  18. Prognostic value of MYCN and ID2 overexpression in neuroblastoma

    Pediatric Blood & Cancer

    Volume 45, Issue 7, December 2005, Pages: 909–915, Miguel Alaminos, William L. Gerald and Nai-Kong V. Cheung

    Version of Record online : 26 JUL 2005, DOI: 10.1002/pbc.20505

  19. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines

    Molecular Carcinogenesis

    Volume 49, Issue 3, March 2010, Pages: 224–234, Elizabeth A. Beierle, Xiaojie Ma, Angelica Trujillo, Elena V. Kurenova, William G. Cance and Vita M. Golubovskaya

    Version of Record online : 2 NOV 2009, DOI: 10.1002/mc.20592

  20. You have free access to this content
    Enlarged and prominent nucleoli may be indicative of MYCN amplification


    Volume 103, Issue 1, 1 January 2005, Pages: 174–180, Chie Kobayashi, Hector L. Monforte-Munoz, Robert B. Gerbing, Daniel O. Stram, Katherine K. Matthay, John N. Lukens, Robert C. Seeger and Hiroyuki Shimada

    Version of Record online : 17 NOV 2004, DOI: 10.1002/cncr.20717